Prognos is a healthcare technology company using AI and advanced analytics. More than 7 Billion data points, 135 million patient files, and 500 proprietary algorithms put into play to drive early detection of chronic and ID-delayed diseases.

Merck is onboard with investment…Cigna has rolled it out…and we have their CMO Dr. Jason Bhan with us today.

In this episode, Dr. Steve and Dr. Bhan discuss:

  • The power of Prognos’ AI platform and risk-assessment engine
  • Prognos vs. IBM’s Watson
  • A wide reach into life science, payer, and diagnostics industries
  • Their bold new approach into early disease detection